|
Avastin NOT recommended for BC
http://www.bloomberg.com/apps/news?p...bEw&refer=home
Dec. 5 (Bloomberg) -- Genentech Inc.'s Avastin, the drugmaker's second-biggest product, should be rejected for use against breast cancer, U.S. advisers said. Genentech fell the most in more than five years on the New York Stock Exchange before trading was halted.
__________________
Janet
Endometrial Cancer 2002
Mammogram 11/2004
Lumpectomy 12/2004
Stage 1, 9mm DCIS, grade 2, Her2+++, ER/PR negative
Refused A/C as recommened by two oncs.
35 treatments of radiation that ended March 4, 2005
Changed oncologists and began
Taxotere/Herceptin August 2005. Finished Herceptin July 2006
|
Linear Mode
